Impact of bivalirudin use on outcomes in nonagenarians undergoing percutaneous coronary intervention

Journal of Interventional Cardiology

Volumn 22, Issue 1, 2009, Pages 61-67

  Lemesle, Gilles ^a   Bonello, Laurent ^a   De Labriolle, Axel ^a   Steinberg, Daniel H ^a   Roy, Probal ^a   Slottow, Tina L Pinto ^a   Torguson, Rebecca ^a   Kaneshige, Kimberly ^a   Xue, Zhenyi ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HIRULOG;

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

AGED, 80 AND OVER; ANTICOAGULANTS; COHORT STUDIES; COMORBIDITY; CORONARY ARTERY DISEASE; FEMALE; HEPARIN; HIRUDINS; HOSPITAL MORTALITY; HUMANS; MALE; PEPTIDE FRAGMENTS; PROPORTIONAL HAZARDS MODELS; RECOMBINANT PROTEINS; STENTS; TREATMENT OUTCOME;

EID: 60349100847     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2008.00422.x     Document Type: Article

References (28)

1. Assali AR, Moustapha A, Sdringola S, et al. The dilemma of success: Percutaneous coronary interventions in patients > or = 75 years of age - successful but associated with higher vascular complications and cardiac mortality. Catheter Cardiovasc Interv 2003 59 : 195 199.
2. Batchelor WB, Anstrom KJ, Muhlbaier LH, et al. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: Results in 7,472 octogenarians. National Cardiovascular Network collaboration. J Am Coll Cardiol 2000 36 : 723 730.
3. Hassani SE, Wolfram RM, Kuchulakanti PK, et al. Percutaneous coronary intervention with drug-eluting stents in octogenarians: Characteristics, clinical presentation, and outcomes. Catheter Cardiovasc Interv 2006 68 : 36 43.
4. Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: Four-year follow-up of the randomized trial of invasive versus medical therapy in elderly patients (TIME). Circulation 2004 110 : 1213 1218.
5. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): A randomised trial. Lancet 2001 358 : 951 957.
6. Feldman DN, Gade CL, Slotwiner AJ, et al. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry). Am J Cardiol 2006 98 : 1334 1339.
7. Kobayashi Y, Mehran R, Mintz GS, et al. Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or = 80 years old versus those <80 years old. Am J Cardiol 2003 92 : 443 446.
8. Little T, Milner MR, Lee K, et al. Late outcome and quality of life following percutaneous transluminal coronary angioplasty in octogenarians. Cathet Cardiovasc Diagn 1993 29 : 261 266.
9. Weintraub WS, Veledar E, Thompson T, et al. Percutaneous coronary intervention outcomes in octogenarians during the stent era (National Cardiovascular Network). Am J Cardiol 2001 88 : 1407 1410, A6.
10. Teplitsky I, Assali A, Lev E, et al. Results of percutaneous coronary interventions in patients > or = 90 years of age. Catheter Cardiovasc Interv 2007 70 : 937 943.
11. Lee MS, Zimmer R, Pessegueiro A, et al. Outcomes of nonagenarians who undergo percutaneous coronary intervention with drug-eluting stents. Catheter Cardiovasc Interv 2008 71 : 526 530.
12. Moreno R, Salazar A, Banuelos C, et al. Effectiveness of percutaneous coronary interventions in nonagenarians. Am J Cardiol 2004 94 : 1058 1060.
13. Smith SC Jr., Feldman TE, Hirshfeld JW Jr., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention - summary article: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/SCAI writing committee to update the 2001 guidelines for percutaneous coronary intervention). J Am Coll Cardiol 2006 47 : 216 235.
14. Myler RK, Shaw RE, Stertzer SH, et al. Lesion morphology and coronary angioplasty: Current experience and analysis. J Am Coll Cardiol 1992 19 : 1641 1652.
15. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987 76 : 142 154.
16. Bauer T, Koeth O, Junger C, et al. Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction. Eur Heart J 2007 28 : 2873 2878.
17. Feit F, Voeltz MD, Attubato MJ, et al. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial. Am J Cardiol 2007 100 : 1364 1369.
18. Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003 92 : 930 935.
19. Yatskar L, Selzer F, Feit F, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: Data from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2007 69 : 961 966.
20. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY trial. J Am Coll Cardiol 2007 49 : 1362 1368.
21. Stone GW, White HD, Ohman EM, et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A subgroup analysis from the acute catheterization and urgent intervention triage strategy (ACUITY) trial. Lancet 2007 369 : 907 919.
22. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008 358 : 2218 2230.
23. Kastrati A, Neumann FJ, Mehilli J, et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 2008 359 : 688 696.
24. Voeltz MD, Patel AD, Feit F, et al. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 2007 99 : 1513 1517.
25. Vlaar PJ, Lennon RJ, Rihal CS, et al. Drug-eluting stents in octogenarians: Early and intermediate outcome. Am Heart J 2008 155 : 680 686.
26. Dacey LJ, Likosky DS, Ryan TJ Jr., et al. Long-term survival after surgery versus percutaneous intervention in octogenarians with multivessel coronary disease. Ann Thorac Surg 2007 84 : 1904 1911 discussion 1904-1911.
27. Yan BP, Gurvitch R, Duffy SJ, et al. An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry. Catheter Cardiovasc Interv 2007 70 : 928 936.
28. Wenaweser P, Ramser M, Windecker S, et al. Outcome of elderly patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. Catheter Cardiovasc Interv 2007 70 : 485 490.